from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2097c/pafA

LFCtreatmentdescriptionclass of inhibitor

-2.024

Amikacinug/mL Amikacintranslation

-2.008

Cap5-10ug/mL Capreomycintranslation

-3.086

Rox10-50 ug/mL Roxithromycintranslation

0.010

SM2-5 ug/mL Streptomycintranslation

-3.974

Tet5-10 ug/mL Tetracyclinetranslation

-0.916

Rif0.2-5ug/mL Rifampicintranscription

-0.436

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.698

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.763

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.317

CPZ10-50 ug/mL Chlorpromazinerespiration

0.498

Clofazimine10-13 ug/mL Clofaziminerespiration

0.241

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.196

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.495

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.429

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.124

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.548

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.959

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.744

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.648

KCN5-20 ug/mL Potassium cyaniderespiration

0.544

NaN30.2-2 mM Sodium aziderespiration

1.398

Nigericin50 uM Nigericinrespiration

-0.338

TRC10-150 ug/mL Triclosanrespiration

0.297

TRZ10-25 ug/mL Thioridazinerespiration

-0.851

Valinomycin0.5-10 uM Valinomycinrespiration

0.457

ZnSO42 mM ZnSO4respiration

1.022

menadione6-10 ug/mL Menadionerespiration

-0.258

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.277

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.429

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.492

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.095

NRP_1Non-replicating persistence stage 1dosRassociated

0.451

Amp0.2mg/mL AmpicillincellWall

-0.599

Cephalexin20-100 ug/mL CephalexincellWall

-0.121

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.170

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.226

EMB10-20 ug/mL EthambutolcellWall

-0.160

Eta12-40 ug/mL EthionamidecellWall

0.337

INH0.2-0.4 ug/mL IsoniazidcellWall

0.020

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.719

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.070

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.627

BZA0.12 mg/mL BenzamidearomaticAmides

0.243

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.895

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.103

H2O24 mM hydrogen peroxideDNAdamaging

-0.325

Levo10 ug/mL LevofloxacinDNAdamaging

-0.213

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.271

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.129

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.568

UVUV-irradiationDNAdamaging

-0.213

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.357

Antimycin12.5-50 ug/mL Antimycin A?

-0.016

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.037

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.096

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.888

PA8240.2-2 ug/mL PA-824?

0.770

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.315

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.147

Verapamil50 uM Verapamil?

-0.480

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.035

methoxatin10-20 ug/mL Methoxatin?